USCAP Update On Hematopathology Classification: The International Consensus Classification Perspective 2023

USCAP Update On Hematopathology Classification: The International Consensus Classification Perspective 2023

Regular price
$90.00
Sale price
$90.00
Regular price
Sold out
Unit price
per 

Videos+PDFs


Original release date: November 17, 2023


Course Description

The diagnosis and classification of hematopoietic tumors is increasingly complex and evolves rapidly. The introduction of the International Consensus Classification (ICC) of Myeloid and Lymphoid Neoplasms and publication of the proposed 5th edition World Health Organization (WHO) classification of the same tumors is the latest stage in this evolution and both further expand the clinical, morphologic, immunophenotypic and molecular genetic criteria for diagnosis. Join USCAP and learn from developers of the ICC on what is new in the classification of these tumors and how the ICC and proposed WHO compare. Leading clinical experts in hematology/oncology will also provide clinician perspectives on the importance of proper disease classification. The course will include disease specific lectures as well as opportunities to join experts in interactive microscopy sessions to gain practical knowledge on how to implement the new disease classifications into practice.





Small B-cell Neoplasms – Rebecca King, MD



Section: 1 Presentation 1 Document



Lymphoplasmacytic Lymphoma, Myeloma and Related Neoplasms – James Cook, MD, PhD 

Section: 1 Presentation 1 Document



Cutaneous Lymphomas – John Goodlad, MD, MBChB, FRCPath 

Section: 1 Presentation 1 Document



Clinician Perspective on the Diagnosis of B-cell Lymphoma – Jane Winter, MD 

Section: 1 Presentation 1 Document



Aggressive B-cell Lymphomas – Elias Campo, MD, PhD 

Section: 1 Presentation 1 Document



Hodgkin Lymphoma and Grey Zone Lymphomas – Elias Campo, MD, PhD 

Section: 1 Presentation 1 Document



T-cell Lymphoma – Leticia Quintanilla-Fend, MD 

Section: 2 Presentations 1 Document



Molecular Approach to Malignant Lymphoma – Laurence de Leval, MD, PhD 

Section: 1 Presentation 1 Document



Clinician Perspective on the Diagnosis of T-cell Neoplasms – Steve Horwitz, MD 

Section: 1 Presentation 1 Document



Immunodeficiency-associated Lymphoproliferative Disorders – Elaine Jaffe, MD 

Section: 1 Presentation 1 Document



Histiocytic and Dendritic Cell Neoplasms – Elaine Jaffe, MD 

Section: 1 Presentation 1 Document



Acute Lymphoblastic Leukemia/Lymphoma and Acute Leukemias of Ambiguous Lineage – Michael Borowitz, MD, PhD 

Section: 1 Presentation 1 Document



Clonal Hematopoiesis and Myelodysplastic Syndromes – Robert Hasserjian, MD 

Section: 1 Presentation 1 Document



Myeloproliferative Neoplasms – Hans-Michael Kvasnicka, MD, PhD 

Section: 1 Presentation 1 Document






Mastocytosis – Attilio Orazi, MD, FRCPath



Section: 1 Presentation 1 Document



Clinician Perspective on the Diagnosis of Eosinophilic and Mast Cell Disorders – Ayalew Tefferi, MD 

Section: 1 Presentation 1 Document




Myeloid/lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions – Sa Wang, MD 

Section: 1 Presentation 1 Document



Myelodysplastic/myeloproliferative Neoplasms – Attilio Orazi, MD, FRCPath 

Section: 1 Presentation 1 Document



Pediatric and/or Germline Disorders – Katherine Calvo, MD, PhD 

Section: 1 Presentation 1 Document



Acute Myeloid Leukemia – Daniel Arber, MD 

Section: 1 Presentation 1 Document



Clinician Perspective on the Diagnosis of Acute Myeloid Leukemia – Olatoyosi Odenike, MD 

Section: 1 Presentation 1 Document



Molecular Approach to Myeloid Disorders – Adam Bagg, MD 

Section: 1 Presentation 1 Document